摘要

Compound Kushen Injection (CKI) is Sophora flavescens and Heterosmilacis japonicae extract. Meta-analysis confirmed that CKI plus transcatheter arterial chemoembolization (TACE) is more superior to TACE alone for unresectable hepatocellular carcinoma (UHCC) patients.